Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagida Bibi

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Nature Communications|March 11, 2022
Divergent trajectories of antiviral memory after SARS-CoV-2 infectionAdriana Tomic, Donal T Skelly, Ane Ogbe, et al.
Nature Communications|March 30, 2021
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2Alain Townsend, Pramila Rijal, Julie Xiao, et al.
Cell|July 9, 2021
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serumChang Liu, Helen M Ginn, Wanwisa Dejnirattisai, et al.
Med (New York, N.Y.)|March 2, 2023
Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimensShona C Moore, Barbara Kronsteiner, Stephanie Longet, et al.
Lancet (London, England)|April 2, 2021
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trialKatherine R W Emary, Tanya Golubchik, Parvinder K Aley, et al.
Lancet (London, England)|November 22, 2020
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trialMaheshi N Ramasamy, Angela M Minassian, Katie J Ewer, et al.
Wellcome Open Research|March 22, 2021
Antibody testing for COVID-19: A report from the National COVID Scientific Advisory PanelEmily R Adams, Mark Ainsworth, Rekha Anand, et al.
Lancet (London, England)|February 22, 2021
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trialsMerryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, et al.
Lancet (London, England)|December 11, 2020
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKMerryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Nature Communications|March 11, 2022
Divergent trajectories of antiviral memory after SARS-CoV-2 infectionAdriana Tomic, Donal T Skelly, Ane Ogbe, et al.
Nature Communications|March 30, 2021
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2Alain Townsend, Pramila Rijal, Julie Xiao, et al.
Cell|July 9, 2021
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serumChang Liu, Helen M Ginn, Wanwisa Dejnirattisai, et al.
Med (New York, N.Y.)|March 2, 2023
Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimensShona C Moore, Barbara Kronsteiner, Stephanie Longet, et al.
Lancet (London, England)|April 2, 2021
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trialKatherine R W Emary, Tanya Golubchik, Parvinder K Aley, et al.
Lancet (London, England)|November 22, 2020
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trialMaheshi N Ramasamy, Angela M Minassian, Katie J Ewer, et al.
Wellcome Open Research|March 22, 2021
Antibody testing for COVID-19: A report from the National COVID Scientific Advisory PanelEmily R Adams, Mark Ainsworth, Rekha Anand, et al.
Lancet (London, England)|February 22, 2021
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trialsMerryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, et al.
Lancet (London, England)|December 11, 2020
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKMerryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, et al.
Pageof 6